Literature DB >> 6279778

Atypical patterns of neural infection produced in mice by drug-resistant strains of herpes simplex virus.

H J Field, J R Anderson, P Wildy.   

Abstract

Mice inoculated intracerebrally (i.c.) with a mutant strain of HSV were found to develop cataracts 1 to 2 months after inoculation. Cataract formation was subsequently shown to follow an acute retinitis which commenced within 1 week of inoculation. The mutant had been selected for high resistance to the nucleoside analogue acyclovir and has been shown previously to be defective in the induction of thymidine kinase and also to express an altered DNA polymerase. The LD50 for mice inoculated i.c. was greater than 10(5) p.f.u. compared with approx 7 p.f.u. for the parental strain. Studies of virus replication following i.c. inoculation with a sublethal dose of the mutant revealed that only small amounts of infectious virus were produced in the brain, but during a period from 6 to 12 days after inoculation vigorous replication occurred in retinal tissue, producing very high titres of virus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279778     DOI: 10.1099/0022-1317-59-1-91

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene.

Authors:  H J Field; D M Coen
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

2.  Discrimination of herpes simplex virus types 1 and 2 cerebral infections in a rat model.

Authors:  T Bergström; B Svennerholm; N Conradi; P Horal; A Vahlne
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Replication of herpes simplex virus type 1 within trigeminal ganglia is required for high frequency but not high viral genome copy number latency.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Resistance of herpes simplex virus to antiviral agents. Is it clinically important?

Authors:  C Crumpacker
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

5.  Neurovirulence of an herpes simplex type 1 thymidine kinase negative mutant determined by virus biochemical defect and host immune system in mice. Brief report.

Authors:  Y J Gordon; P L Simon; J A Armstrong
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

6.  Cooperative effects between two acyclovir resistance loci in herpes simplex virus.

Authors:  G Darby; M J Churcher; B A Larder
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

7.  Genetic variability of herpes simplex virus: development of a pathogenic variant during passaging of a nonpathogenic herpes simplex virus type 1 virus strain in mouse brain.

Authors:  H C Kaerner; C H Schröder; A Ott-Hartmann; G Kümel; H Kirchner
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

8.  An animal model of ocular herpes. Keratitis, retinitis and cataract in the mouse.

Authors:  J R Anderson; H J Field
Journal:  Br J Exp Pathol       Date:  1984-06

9.  Replication of thymidine kinase deficient herpes simplex virus type 1 in neuronal cell culture: infection of the PC 12 cell.

Authors:  R Rubenstein; R W Price
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

Review 10.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.